Abstract:Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, Saro Kobayashi, Koichi Hirata Department of Neurology, Dokkyo Medical University, Mibu, Japan Correspondence: Keisuke Suzuki, Department of Neurology, Dokkyo Medical University, 880 Kitakobayashi, Shimotsuga, Mibu, Tochigi, 321-0293, Japan, Tel +81-282-86-1111, Fax +81-282-86-5884, Email Central sensitization (CS) is an increase in the responsiveness of nociceptive neurons in the central nervous system to their normal afferent input. As a result, even minor irritation can induce severe pain, leading to the chronicity and severity of various diseases, such as neurological disorders. CS is associated with migraine, which is a major neurological disorder that inflicts a high disability in daily life. Specifically, CS is thought to be involved in the pathogenesis of cutaneous allodynia as well as chronification of migraine. In this article, we reviewed the association between CS and migraine, including pathophysiological aspects and evidence from clinical studies. We suggest that appropriate screening and management of CS in migraine could further improve the quality of life of migraine patients. Keywords: migraine, central sensitization, cutaneous allodynia, restless legs syndrome Central sensitization (CS) occurs when the function of circuits in nociceptive pathways is enhanced and results in abnormal sensitivity; it is defined as "increased responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold afferent input" according to the International Association for the Study of Pain. 1 An original work by Woolf 2 showed that a peripheral injury-induced increase in the excitability of spinal cord neurons profoundly modifies the gain of the somatosensory system. While peripheral sensitization is an increase in the sensitivity of the local peripheral terminals of sensory fibers that innervate injured tissue, CS involves the central nervous system. Moreover, CS can occur due to tissue damage after peripheral nerve injury but also in diseases without any peripheral pathology, such as migraine, fibromyalgia, temporomandibular joint disease, and irritable bowel syndrome. 3 A multicenter case–controlled study showed higher central sensitization inventory (CSI) scores in patients with various neurological, psychological, and pain disorders, including migraine, than in healthy controls. Additionally, CS-related symptoms were associated with pain severity, interference of pain with daily activities, and depressive symptoms in the patient group. 4 Therefore, the management of CS-related pain and symptoms in various pain-related diseases is urgent. Migraine is a major neurological disorder that inflicts a high disability in daily life, and many patients suffer from intractable pain. Although genetic predisposition and activation of the trigeminal vasculature are considered the main pathophysiological factors for migraine, 5 CS is thought to be involved in the pathogenesis of cutaneous allodynia (CA) and chronicity in migraine. In this article, we provide a narrative review of CS in people with migraine. We performed a literature search of MEDLINE, a PUBMED database, and Web of Science to retrieve articles published in the English language between March and May 2022 using a combination of keywords such "migraine" and "central sensitization" or "central sensitization syndrome". The important literature that was retrieved by handsearching was also included in this review. CS clinically manifests as CA (a reduction in the pain threshold of the skin), hyperalgesia (an increase and prolonged responsiveness to noxious stimuli) and secondary hyperalgesia (a spread of sensitivity outside of the region of injury into noninjured tissue). 3,6 To diagnose pain due to CS, three major criteria are recommended: 1) experiencing pain disproportionate to the nature and extent of injury or pathology; 2) a diffuse pain distribution and the presence of allodynia and hyperalgesia; and 3) hypersensitivity of senses unrelated to the musculoskeletal system. 7 People suffering pain due to CS show hypersensitivity to bright lights, touch, noise, pesticides, mechanical pressure, medication and temperature (low and high), and these symptoms may also be associated with fatigue, sleep disturbances, unrefreshing sleep, concentration difficulties, a feeling of swelling in the limbs, tingling and numbness. 7 These characteristics are important in differentiating pain due to CS from neuropathic pain. The CSI is a widely used self-administered questionnaire for assessing CS-related symptoms in clinical studies. 8 Part A of the CSI comprises 25 CS-related items with total scores ranging from 0 to 100. A Part A score≥40 contributes to CS diagnosis and can be used as an alternative -Abstract Truncated-

Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease

Symptoms of central sensitization in patients with inflammatory bowel diseases: a case-control study examining the role of musculoskeletal pain and psychological factors

Central and peripheral hypersensitivity in the irritable bowel syndrome

Lactose Intolerance In Irritable Bowel Syndrome Patients With Diarrhoea: The Roles Of Anxiety, Activation Of The Innate Mucosal Immune System And Visceral Sensitivity

Central Sensitization in Neurological, Psychiatric, and Pain Disorders: A Multicenter Case-Controlled Study

Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study

Central Sensitization in Migraine: A Narrative Review

Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjögren's syndrome

An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome

Central sensitization in CRPS patients with widespread pain: a cross-sectional study

Association Between Allergic Diseases And Irritable Bowel Syndrome: A Retrospective Study

Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis

Assessment and manifestation of central sensitisation across different chronic pain conditions

Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain

Scientific Knowledge Graph and Trend Analysis of Central Sensitization: A Bibliometric Analysis

Central sensitization in urogynecological chronic pelvic pain: a systematic literature review

Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses

Extra-intestinal symptoms in patients with irritable bowel syndrome: related to high total IgE levels and atopic sensitization?

Value of the central sensitisation inventory in patients with axial spondyloarthritis

Supraspinal Mechanisms of Intestinal Hypersensitivity

Visceral hypersensitivity is together with psychological distress and female gender associated with severity of IBS-like symptoms in quiescent ulcerative colitis